These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11235463)

  • 1. Rapacuronium bromide.
    Stump L
    J Perianesth Nurs; 2000 Aug; 15(4):258-9. PubMed ID: 11235463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of neuromuscular and cardiovascular effects of two doses of rapacuronium (ORG 9487) versus mivacurium and succinylcholine.
    Miguel R; Witkowski T; Nagashima H; Fragen R; Bartkowski R; Foldes FF; Shanks C
    Anesthesiology; 1999 Dec; 91(6):1648-54. PubMed ID: 10598606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hemodynamic effects of rapacuronium in patients with coronary artery disease: succinylcholine and vecuronium compared.
    Delboy NJ; Tomichek RC; Shields JA
    Anesth Analg; 2002 May; 94(5):1100-6, table of contents. PubMed ID: 11973169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Rap" in the streets: a retrospective look at the use of rapacuronium for prehospital rapid sequence induction.
    Koschel MJ
    Air Med J; 2001; 20(5):18-9. PubMed ID: 11552106
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical pharmacology of rapacuronium bromide, a new short-acting neuromuscular blocking agent.
    Larijani GE; Zafeiridis A; Goldberg ME
    Pharmacotherapy; 1999 Oct; 19(10):1118-22. PubMed ID: 10512060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapacuronium bromide: a review of its use in anaesthetic practice.
    Onrust SV; Foster RH
    Drugs; 1999 Nov; 58(5):887-918. PubMed ID: 10595867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of rapacuronium bromide.
    Wight WJ; Wright PM
    Clin Pharmacokinet; 2002; 41(13):1059-76. PubMed ID: 12403643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potency (ED50) and cardiovascular effects of rapacuronium (Org 9487) during narcotic-nitrous oxide-propofol anesthesia in neonates, infants, and children.
    Kaplan RF; Fletcher JE; Hannallah RS; Bui DT; Slaven JS; Darrow EJ; Tsai KT
    Anesth Analg; 1999 Nov; 89(5):1172-6. PubMed ID: 10553829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapacuronium: first experience in clinical practice.
    Bartkowski RR; Witkowski TA
    Eur J Anaesthesiol Suppl; 2001; 23():90-3. PubMed ID: 11766254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rapacuronium: a new, non-depolarizing muscle relaxant for rapid intubation?].
    Busley R; Blobner M; Kochs E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Feb; 35(2):112-4. PubMed ID: 10719607
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapacuronium: clinical pharmacology.
    Mirakhur RK; McCourt KC
    Eur J Anaesthesiol Suppl; 2001; 23():77-82. PubMed ID: 11766252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can succinylcholine be abandoned?
    Cook DR
    Anesth Analg; 2000 May; 90(5 Suppl):S24-S28. PubMed ID: 10809515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the intubation conditions provided by rapacuronium (ORG 9487) or succinylcholine in humans during anesthesia with fentanyl and propofol.
    Fleming NW; Chung F; Glass PS; Kitts JB; Kirkegaard-Nielsen H; Gronert GA; Chan V; Gan TJ; Cicutti N; Caldwell JE
    Anesthesiology; 1999 Nov; 91(5):1311-7. PubMed ID: 10551582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapacuronium: why did it fail as a replacement for succinylcholine?
    White PF
    Br J Anaesth; 2002 Feb; 88(2):163-5. PubMed ID: 11878650
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged duration of neuromuscular block with rapacuronium in the presence of sevoflurane.
    Cara DM; Armory P; Mahajan RP
    Anesth Analg; 2000 Dec; 91(6):1392-3, TOC. PubMed ID: 11093986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapacuronium (Org 9487): do we have a replacement for succinylcholine?
    Goulden MR; Hunter JM
    Br J Anaesth; 1999 Apr; 82(4):489-92. PubMed ID: 10472209
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolongation of rapacuronium neuromuscular blockade by clindamycin and magnesium.
    Sloan PA; Rasul M
    Anesth Analg; 2002 Jan; 94(1):123-4, table of contents. PubMed ID: 11772813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of rapacuronium in infants and children with intravenous and intramuscular administration.
    Reynolds LM; Infosino A; Brown R; Hsu J; Fisher DM
    Anesthesiology; 2000 Feb; 92(2):376-86. PubMed ID: 10691223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacokinetic-dynamic explanation of the rapid onset-offset of rapacuronium.
    Proost JH; Wright PM
    Eur J Anaesthesiol Suppl; 2001; 23():83-9. PubMed ID: 11766253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular rapacuronium in infants and children: dose-ranging and tracheal intubating conditions.
    Reynolds LM; Infosino A; Brown R; Hsu J; Fisher DM
    Anesthesiology; 1999 Nov; 91(5):1285-92. PubMed ID: 10551578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.